IRIS - Res&Arch Institutional Research Information System - Research & Archive

Ingrosso, Gianluca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.404
EU - Europa 760
AS - Asia 510
AF - Africa 3
OC - Oceania 2
SA - Sud America 1
Totale 2.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.394
IE - Irlanda 352
SG - Singapore 253
IT - Italia 226
HK - Hong Kong 155
CN - Cina 58
RU - Federazione Russa 39
FR - Francia 25
DE - Germania 24
UA - Ucraina 21
CH - Svizzera 12
FI - Finlandia 11
KR - Corea 11
VN - Vietnam 11
CA - Canada 9
GB - Regno Unito 8
SE - Svezia 8
AT - Austria 7
NL - Olanda 7
CZ - Repubblica Ceca 5
IL - Israele 5
BE - Belgio 4
JP - Giappone 4
PL - Polonia 4
UZ - Uzbekistan 4
LB - Libano 3
AU - Australia 2
ES - Italia 2
GR - Grecia 2
IN - India 2
NG - Nigeria 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
CI - Costa d'Avorio 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NO - Norvegia 1
PE - Perù 1
SI - Slovenia 1
Totale 2.680
Salva come PNG Salva come JPEG
Città #
Dublin 350
Chandler 255
Singapore 199
Boardman 158
Hong Kong 155
Altamura 120
San Mateo 119
Santa Clara 107
Lawrence 73
Medford 73
Princeton 73
Andover 33
Wilmington 28
Houston 21
Ann Arbor 19
Beijing 18
Des Moines 18
Saint Petersburg 17
Redmond 16
Norwalk 14
Perugia 12
Dong Ket 11
Los Angeles 11
Seoul 11
Falls Church 10
San Paolo di Civitate 9
Menlo Park 8
Milan 8
Paris 8
Redwood City 8
Toronto 8
Rome 7
Lausanne 6
New York 6
Prato 6
Terni 6
Dallas 5
Lappeenranta 5
Munich 5
Bologna 4
Brussels 4
Fairfield 4
Helsinki 4
Amsterdam 3
Ashburn 3
Frankfurt Am Main 3
Kiryat Ono 3
Moscow 3
Nanjing 3
Novosibirsk 3
Ospedaletto Lodigiano 3
Ravenna 3
Sesto Fiorentino 3
Shanghai 3
Breda 2
Brno 2
Castello di Godego 2
Chiba 2
Chicago 2
Edinburgh 2
Florence 2
Frankfurt am Main 2
Guangzhou 2
Hradec Kralove 2
Jacksonville 2
Kiev 2
Lagos 2
Madison 2
New Delhi 2
Rzeszów 2
Tokyo 2
Woodbridge 2
Abidjan 1
Atlanta 1
Avigliano 1
Berlin 1
Brescia 1
Cambridge 1
Catania 1
Clifton 1
Dalian 1
Dubai 1
Ergolding 1
Gunzenhausen 1
Hangzhou 1
Helmond 1
Hendersonville 1
Istanbul 1
Izmir 1
Kazan 1
Köln 1
Lima 1
London 1
Ludwigshafen 1
Madrid 1
Marsciano 1
New Orleans 1
Nuremberg 1
Olomouc 1
Pamplona 1
Totale 2.129
Salva come PNG Salva come JPEG
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 102
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 62
Interfraction prostate displacement during image-guided radiotherapy using intraprostatic fiducial markers and a cone-beam computed tomography system: A volumetric off-line analysis in relation to the variations of rectal and bladder volumes 59
Acute and late toxicity after three-dimensional conformal image-guided radiotherapy for localized prostate cancer 54
Helical tomotherapy re-irradiation for patients affected by local radiorecurrent prostate cancer 47
Evaluation of serrated intraprostatic gold coils positional stability using on-board cone beam computed tomography scans acquired throughout the radiation treatment course 46
Guidelines on prostate carcinoma - AIRO, 2016 45
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 45
Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence 45
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: New evidence from a multicentric study 43
Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy? 43
Prostate Cancer Recurrence in Kidney Transplant Recipient 15 Years After Radical Prostatectomy: A Case Report. 43
Physician And Patient Barriers To Radiotherapy Service Access: Treatment Referral Implications 42
Whole breast external beam radiotherapy in elderly patients affected by left-sided early breast cancer: a dosimetric comparison between two simple free-breathing techniques 42
Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer 42
Breakdown of symbiosis in radiation-induced oral mucositis 42
Zinc-L-carnosine prevented dysphagia in breast cancer patients undergoing adjuvant radiotherapy: Results of a phase III randomized trial 41
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy 41
High-resolution microultrasound imaging for bladder cancer: the birth of a new diagnostic tool? 41
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 41
Radiotherapy for papillary tumor of the pineal region: A systematic review of the literature. 40
Combining abiraterone and radiotherapy in prostate cancer patients who progressed during abiraterone therapy 39
Current therapeutic options in metastatic castration-resistant prostate cancer 39
Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer 39
Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy 38
Endoscopic intravesical fibrin glue application in the treatment of refractory hemorrhagic radiation cystitis: A single cohort pilot study 38
Stereotactic radiotherapy for brain metastases: Imaging tools and dosimetric predictive factors for radionecrosis 37
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 37
Tomotherapy-based moderate hypofractionation for localized prostate cancer: a mono-institutional analysis 36
Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients 35
Pulmonary function in stereotactic body radiotherapy with helical tomotherapy for primary and metastatic lung lesions 35
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 35
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 35
Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience 34
Impact of gastrointestinal side effects on patients’ reported quality of life trajectories after radiotherapy for prostate cancer: Data from the prospective, observational pros-it CNR study 34
Dosimetric effect of Elekta Beam Modulator micromultileaf in three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer 33
The time factor in oncology: Consequences on tumour volume and therapeutic planning 33
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 33
Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis 32
Hypofractionated stereotactic radiotherapy in combination with whole brain radiotherapy for brain metastases 32
Radiotherapy at oligoprogression for metastatic castration-resistant prostate cancer patients: a multi-institutional analysis 32
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 31
Volumetric image-guided conformal radiotherapy for localized prostate cancer: Analysis of dosimetric and clinical factors affecting acute and late toxicity 30
Cone-beam computed tomography in hypofractionated stereotactic radiotherapy for brain metastases 30
Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients 28
Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience 28
Stereotactic radiotherapy for liver oligometastases 28
Stereotactic radiotherapy for brain oligometastases 28
Re: PSMA-Guided Metastases Directed Therapy for Bone Castration Sensitive Oligometastatic Prostate Cancer: A Multi-Institutional Study 27
The role of adjuvant radiother apy in the treatment of papillary tumors of the pineal region: Some general considerations and a case report 27
Stereotactic ablative radiotherapy in castration-resistant prostate cancer patients with oligoprogression during androgen receptor-targeted therapy 27
Stereotactic radiotherapy for bone oligometastases 27
Transient effects of tumor location on the functional architecture at rest in glioblastoma patients: Three longitudinal case studies 26
Intensity-modulated and 3D-conformal radiotherapy in hypofractionated prostate cancer treatment using Elekta Beam Modulator (TM) micro-MLC: A dosimetric analysis 26
Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: A retrospective analysis of acute skin toxicity and dose inhomogeneities 26
Detection rate, pattern of relapse and influence on therapeutic decision of PSMA PET/CT in patients affected by biochemical recurrence after radical prostatectomy, a retrospective case series 26
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change 25
Preliminary experience of a predictive model to define rectal volume and rectal dose during the treatment of prostate cancer 25
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row: Nodal oligorecurrent prostate cancer 25
Intra-parotid facial nerve schwannoma with intra-temporal extension; A case report. Is there a role for stereotactic radiotherapy? 25
Predicting genitourinary toxicity in three-dimensional conformal radiotherapy for localized prostate cancer: A dose-volume parameters analysis of the bladder 25
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 24
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 24
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 24
Volumetric image-guided highly conformal radiotherapy of the prostate bed: Toxicity analysis 24
Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approach: SBRT in oligometastatic elderly patients 24
Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis 24
Oligometastatic prostate cancer: The game is afoot 24
High-dose-rate brachytherapy with surface applicator in penile cancer 24
Personalization in Modern Radiation Oncology: Methods, Results and Pitfalls. Personalized Interventions and Breast Cancer 24
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance 23
Retro-orbital granulocytic sarcoma: Case report 23
Image-guided-radiotherapy retreatment of spine metastasis: A case report and radiobiological evaluation 22
The impact of ionizing irradiation on liver detoxifying enzymes. A re-investigation 22
Stereotactic radiotherapy for oligometastases in the lymph nodes 22
Bone Health Care Pathway for Non-metastatic Prostate Cancer Patients on Radiation and Androgen Deprivation Therapy 21
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 21
A systematic review and meta-analysis on non-metastatic castration resistant prostate cancer: The radiation oncologist's perspective 20
Stereotactic radiotherapy for lung oligometastases 20
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 19
Effect of internal port on dose distribution in post-mastectomy radiotherapy for breast cancer patients after expander breast reconstruction 18
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review 17
Radiotherapy in the era of COVID-19 17
Stereotactic body radiotherapy (SBRT) in combination with drugs in metastatic kidney cancer: A systematic review 17
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 16
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study 15
Toxicity after moderately hypofractionated versus conventionally fractionated prostate radiotherapy: A systematic review and meta-analysis of the current literature 15
PSMA-guided metastases directed therapy for bone castration sensitive oligometastatic prostate cancer: a multi-institutional study 13
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus 12
Choline PET/CT in recurrent prostate cancer 11
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE) 10
Editorial: Interaction Between Modern Radiotherapy and Novel Drugs in Prostate Cancer: Future Perspectives 10
How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO) 9
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 9
Editorial: Reviews in genitourinary oncology 8
The investigational role of cytoreductive stereotactic ablative radiation therapy (SABR) to the primary tumor in metastatic kidney cancer 3
Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope? 2
Totale 2.883
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.790
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.790
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202039 0 0 0 0 1 0 5 0 5 6 18 4
2020/2021146 2 3 3 2 98 3 18 2 2 1 1 11
2021/2022464 1 52 0 6 4 5 2 152 11 33 48 150
2022/20231.118 77 264 14 50 64 97 10 60 432 3 40 7
2023/2024519 25 48 24 15 6 0 141 6 34 14 97 109
2024/2025452 23 120 45 40 224 0 0 0 0 0 0 0
Totale 2.883